174 related articles for article (PubMed ID: 24126321)
1. [In vitro study over statins effects on cellular growth curves and its reversibility with mevalonate].
Millan Núñez-Cortés J; Alvarez Rodriguez Y; Alvarez Novés G; Recarte Garcia-Andrade C; Alvarez-Sala Walther L
Clin Investig Arterioscler; 2014; 26(1):1-9. PubMed ID: 24126321
[TBL] [Abstract][Full Text] [Related]
2. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells.
Mulhaupt F; Matter CM; Kwak BR; Pelli G; Veillard NR; Burger F; Graber P; Lüscher TF; Mach F
Cardiovasc Res; 2003 Sep; 59(3):755-66. PubMed ID: 14499877
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic vascular protective effects of statins in perioperative medicine.
Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
6. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
7. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
10. [Do the pleiotropic effects of statins have a clinical significance?].
Vergès B
Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1231-5. PubMed ID: 15669365
[TBL] [Abstract][Full Text] [Related]
11. Statins and the endothelium.
Ii M; Losordo DW
Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
13. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
Sadowitz B; Maier KG; Gahtan V
Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of statins on the vascular tissue.
Ikeda U; Shimada K
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
[TBL] [Abstract][Full Text] [Related]
15. Influence of HMG-CoA reductase inhibitors on leptin-induced endothelial cell proliferation, migration, and capillary-like tube formation.
Burgazli KM; Stein NI; Mericliler M; Parahuleva M; Erdogan A
Postgrad Med; 2014 May; 126(3):231-8. PubMed ID: 24918807
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins.
Kwak BR; Mulhaupt F; Mach F
Autoimmun Rev; 2003 Oct; 2(6):332-8. PubMed ID: 14550874
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of statins on cells primarily involved in atherosclerosis.
Chen H; Ikeda U; Shimpo M; Shimada K
Hypertens Res; 2000 Mar; 23(2):187-92. PubMed ID: 10770267
[TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects and cholesterol-lowering therapy.
Shaw SM; Fildes JE; Yonan N; Williams SG
Cardiology; 2009; 112(1):4-12. PubMed ID: 18577880
[TBL] [Abstract][Full Text] [Related]
19. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL
Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712
[TBL] [Abstract][Full Text] [Related]
20. Statins: pros and cons.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Med Clin (Barc); 2018 May; 150(10):398-402. PubMed ID: 29292104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
